Possibilities of Personalized Selection of Psychotherapy for Comorbid Depressive and Stressful Disorders, Targets of Cognitive Behavioral Therapy (CBT) and Person-Centered (Reconstructive) Psychotherapy (LORP)

Background: comorbid depressive and anxiety disorders are the most common combination in clinical practice. These states require a careful approach when choosing treatment methods. The abilities to adapt psychotherapeutic interventions to the needs of patients studied insufficiently. The aim of review was to analyze scientific publications on modern treatment methods, such as cognitive behavioral therapy (CBT) and person-centered (reconstructive) psychotherapy (PCP). Materials and Methods: using keywords “depression”, “stressful disorders”, “comorbidity”, “person-oriented reconstructive psychotherapy”, “cognitive behavioral therapy”, “personalized therapy”, “targets of psychotherapy” a search for articles has been conducted in PubMed, MEDLINE, RSCI, e-Library The purpose of analytical study is to identify the targets of psychotherapeutic interventions for comorbid depressive and stressful disorders in each of the methods. Discussion: the difficulties arising from the comorbidity of depressive and anxiety disorders, as well as their impact according to the choice of therapeutic approach are discussed in most of articles under consideration in connection with the tasks of improving the quality of therapeutic intervention through the selection of a personalized approach to treatment. The characteristics and results of the use of CBT and LORP in the treatment of comorbid conditions are examined, and the targets to which psychotherapeutic interventions should be directed, taking into consideration comorbidity, are identified. The effectiveness of these methods in reducing symptoms and improving the general condition of patients with combined depressive and anxiety disorders is shown. Conclusion: the formation of nosospecific psychotherapeutic strategies can solve problems of increasing the effectiveness of the chosen treatment and improving patients' quality of life

1. Steel Z, Marnane C, Iranpour C, Chey T, Jackson JW, Patel V, Silove D. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013. Int J Epidemiol. 2014;43(2):476–93. doi: 10.1093/ije/dyu038 Epub 2014 Mar 19. PMID: 24648481; PMCID: PMC3997379

2. Remes O, Brayne C, van der Linde R, Lafortune L. A systematic review of reviews on the prevalence of anxiety disorders in adult populations. Brain Behav. 2016;6(7):e00497. doi: 10.1002/brb3.497 PMID: 27458547; PMCID: PMC4951626.

3. Kirpichenko AA. Anxiety and depressive disorders in general medical practice: topical issues and unsolved problems. Medical journal. 2021;2(76):14–22. (In Russ.). doi: 10.51922/1818-426X.2021.2.14

4. Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, Dodel R, Ekman M, Faravelli C, Fratiglioni L, Gannon B, Jones DH, Jennum P, Jordanova A, Jönsson L, Karampampa K, Knapp M, Kobelt G, Kurth T, Lieb R, Linde M, Ljungcrantz C, Maercker A, Melin B, Moscarelli M, Musayev A, Norwood F, Preisig M, Pugliatti M, Rehm J, Salvador-Carulla L, Schlehofer B, Simon R, Steinhausen HC, Stovner LJ, Vallat JM, Van den Bergh P, van Os J, Vos P, Xu W, Wittchen HU, Jönsson B, Olesen J; CDBE2010Study Group. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21(10):718–79. doi: 10.1016/j.euroneuro.2011.08.008 Epub 2011 Sep 15. Erratum in: Eur Neuropsychopharmacol. 2012;22(3):237–8. den Bergh, Peter Van [corrected to Van den Bergh, Peter]. PMID: 21924589.

5. Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci 2015;17(3):327–35. doi: 10.31887/DCNS.2015.17.3

6. Kostyuk, GP, Masyakin AV, Starinskaya MA. On the Prospects of Diagnosis and Treatment of Depressive and Anxiety Disorders in the General Medical Network. Medical Technologies. Assessment and Choice. 2017;4(29):70–75. (In Russ.).

7. Neznanov NG, Vasilyeva AV, Salagay OO. The role of psychotherapy as a medical specialty in public health. Public Health. 2022;2(2):40–57. (In Russ.). doi: 10.21045/2782-1676-2022-2-2-40-57

8. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and ageof-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593–602. doi: 10.1001/arch-psyc.62.6.593

9. Paykel ES. Partial remission, residual symptoms, and relapse in depression. Dialogues Clin Neurosci. 2008;10(4):431–7. doi: 10.31887/DCNS.2008.10.4/espaykel

10. Chisholm D, Sweeny K, Sheehan P, Rasmussen B, Smit F, Cuijpers P, Saxena S. Scaling-up treatment of depression and anxiety: a global return on investment analysis. Lancet Psychiatry. 2016;3(5):415–24. doi: 10.1016/S2215-0366(16)30024-4

11. Jacob KS, Patel V. Classification of mental disorders: a global mental health perspective. Lancet. 2014;383(9926):1433–1435. doi: 10.1016/S0140-6736(13)62382-X PMID: 24759250.

12. Wittchen HU, Kessler RC, Beesdo K, Krause P, Höfter M, Hoyer J. Generalized anxiety and depression in primary care: prevalence, recognition, and management. J Clin Psychiatry. 2002;63(8):24–34. PMID: 12044105

13. Psychotherapy: National guidebook, Ed. Vasileva AV, Karavaeva TA, Neznanov NG. GEOTAR-Media. 2023:992. (In Russ.). doi: 10.33029/9704-7567-6-PSY-2023-1 ISBN 978-5-9704-8559-0

14. Karvasarskij BD, Karavaeva TA, Kolotilycikova EA, Podsadnyj SA, Chernyavskij VA, Chekhlatyj EI. V kn.: Nauchnye trudy V.N. Myasishcheva po probleme nevrozov (k stanovleniyu patogeneticheskoj koncepcii nevroticheskih rasstrojstv). Mental health. 2012;7(74):80. (In Russ.). ISSN 2074-014H

15. Kotova OV, Belyaev AA, Akarachkova ES. State-of-the-art diagnostic and treatment modalities for anxiety and depression. Russian Medical Inquiry. ISSN 2587-6821 (Print), 2686-9918 (Online). 2021;5(10):648–653. (In Russ.). doi: 10.32364/2587-6821-2021-5-10-648-653

16. Choi KW, Kim YK, Jeon HJ. Comorbid Anxiety and Depression: Clinical and Conceptual Consideration and Transdiagnostic Treatment. Adv Exp Med Biol. 2020;1191:219–235. doi: 10.1007/978-981-32-9705-0_14 PMID: 32002932.

17. Möller HJ, Bandelow B, Volz HP, Barnikol UB, Seifritz E, Kasper S. The relevance of ‘mixed anxiety and depression' as a diagnostic category in clinical practice. Eur Arch Psychiatry Clin Neurosci. 2016;266(8):725–736. doi: 10.1007/s00406-016-0684-7 Epub 2016 Mar 22. PMID: 27002521; PMCID: PMC5097109.

18. The International Statistical Classification of Diseases and Related Health Problems. 10th revision (ICD-10) (F00–F99), adapted for use in the Russian Federation Ed. Kazakovcev BA, Golland VB. Russian Ministry of Health 1998:512. (In Russ.).

19. Hecht H, van Calker D. Evidenzbasierte Psychotherapie depressiver Störungen: Akuttherapie und Phasenprophylaxe [Evidence-based psychotherapy of depressive disorders: acute therapy and maintenance therapy]. Psychother Psychosom Med Psychol. 2008;58(8):326–34; quiz 335-8. German. doi: 10.1055/s-2008-1067450

20. Roy-Byrne PP, Davidson KW, Kessler RC, Asmundson GJ, Goodwin RD, Kubzansky L, Lydiard RB, Massie MJ, Katon W, Laden SK, Stein MB. Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry. 2008;30(3):208–25. doi: 10.1016/j.gen-hosppsych.2007.12.006

21. Vertogradova OP, Stepanov IL, Maksimova NM, Vaksman AV, Dikov SYU, Koshkin KA, Moisejcheva OV, Celishchev OV. Clinical and pathogenetic aspects in typology of depression Social and Clinical Psychiatry. 2012;(3):5–9. (In Russ.).

22. Mancebo MC, Eisen JL, Pinto A, Greenberg BD, Dyck IR, Rasmussen SA. The brown longitudinal obsessive compulsive study: treatments received and patient impressions of improvement. J Clin Psychiatry. 2006;67(11):1713–20. doi: 10.4088/jcp.v67n1107

23. Petrova NN, Palkin YuR, Faddeev DV, Zinovieva AG. Comorbidity of depression and anxiety in clinical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(4):31–37. (In Russ.). doi: 10.17116/jnevro202112104131

24. Bandelow B, Allgulander C, Baldwin DS, Costa DLDC, Denys D, Dilbaz N, Domschke K, Eriksson E, Fineberg NA, Hättenschwiler J, Hollander E, Kaiya H, Karavaeva T, Kasper S, Katzman M, Kim YK, Inoue T, Lim L, Masdrakis V, Menchón JM, Miguel EC, Möller HJ, Nardi AE, Pallanti S, Perna G, Rujescu D, Starcevic V, Stein DJ, Tsai SJ, Van Ameringen M, Vasileva A, Wang Z, Zohar J. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders — Version 3. Part I: Anxiety disorders. World J Biol Psychiatry. 2023;24(2):79–117. doi: 10.1080/15622975.2022.2086295 PMID: 35900161

25. Denisova VG. Logical foundation of cognitive behavior therapy. Psychophysiology news 2023;(1):68–79. (In Russ.). doi: 10.34985/f1949-1960-4937-u

26. Vasileva AV. Evolutional depression model in the time of pandemic. Psychotherapy and psychopharmacotherapy alliance. V.M. Bekhterev review of psychiatry and medical psychology 2021;(1):91–101. (In Russ.). doi: 10.31363/2313-7053-2021-1-91-101

27. Crocq MA. The history of generalized anxiety disorder as a diagnostic category. Dialogues Clin Neurosci. 2017;19(2):107–116. doi: 10.31887/DCNS.2017.19.2/macrocq PMID: 28867935; PMCID: PMC5573555.

28. Perna G, Alciati A, Sangiorgio E, Caldirola D, Nemeroff CB. Personalized Clinical Approaches to Anxiety Disorders. Adv Exp Med Biol. 2020;1191:489–521. doi: 10.1007/978-981-32-9705-0_25

29. Bobrov AE, Usatenko EV. The concept of anxiety disorders: main development trends Social and Clinical Psychiatry. 2021;31(4):62–70. (In Russ.).

30. Joyce PR, McKenzie JM, Carter JD, Rae AM, Luty SE, Frampton CM, Mulder RT. Temperament, character and personality disorders as predictors of response to interpersonal psychotherapy and cognitive-behavioural therapy for depression. Br J Psychiatry. 2007;190:503–8. doi: 10.1192/bjp.bp.106.024737 PMID: 17541110.

31. Vasserman LI, Iovlev BV, Karvasarskij BD, Karpova EB. V.N. Myasishchev i medicinskaya psihologiya (k 110-letiyu so dnya rozhdeniya i 30-letiyu so dnya smerti). V.M. Bekhterev review of psychiatry and medical psychology. 2004;(1):22–25. (In Russ.).

32. Isurina G, Karpova E, Zhuravlev A. Psychological concept of relations of V.N. Myasishchev: the doctrine of neuroses and psychotherapy. Psychological Journal. 2021;42(2):36–44. (In Russ.). doi: 10.31857/S020595920014238-7

33. Vasileva AV, Karavaeva TA, Mizinova EB. B.D. Karvasarsky and psychotherapy establishment as a distinct discipline, homo faber, to the 90-th anniversary since birth. V.M. Bekhterev review of psychiatry and medical psychology. 2021;55(4):122–130. (In Russ.). doi: 10.31363/2313-7053-2021-57-4-122-130

34. Kolotil'shchikova EA. The psychological foundations of neurosogenesis: basic concepts and models. The Bulletin of Chuvash Psychiatry and Psychology. 2015;11(1):30–56. (In Russ.).

35. Bagby RM, Psych C, Quilty LC, Ryder AC. Personality and depression. Can J Psychiatry. 2008;53(1):14–25. doi: 10.1177/070674370805300104 PMID: 18286868.

36. Karavaeva TA, Vasileva AV, Poltorak SV. Principles and algorithms of neurotic level anxiety disorders (anxiety-phobic, panic and generalized anxiety disorders) psychotherapy. V.M. Bekhterev review of psychiatry and medical psychology. 2016;(4):42–51. (In Russ.).

37. Karavaeva TA, Vasileva AV, Poltorak SV, Mizinova EB, Belan RM. Diagnostic algorithm and criteria of anxiety disorder. V.M. Bekhterev review of psychiatry and medical psychology. 2015;(4):117–122. (In Russ.).

38. Lyashkovskaya SV. About classification of psychotherapeutic targets and its use for improving the quality of psychotherapy for patients with neurotic disorders. Bulletin of psychotherapy. 2016;59(65):7–28. (In Russ.).

39. Lysenko IS, Karavaeva TA. The definition of psychotherapy targets on the basis of features motivational tendencies in patients with different types of neurotic disorders Bulletin of psychotherapy. 2015;53(58):7–20. (In Russ.).

40. Lysenko IS, Karavaeva TA. The level and the structure of personal and interpersonal conflict in patients with neurotic disorders (systematic study that determines targets and objectives of psychotherapy). Bulletin of psychotherapy. 2016;58(63):57–74. (In Russ.).

41. Vasileva AV, Karavaeva TA. Psychosocial factors of the neurotic disorders treatment and prevention in metropolis. V.M. Bekhterev review of psychiatry and medical psychology. 2020;(2):95–104. (In Russ.). doi: 10.31363/2313-7053-2020-2-95-104

42. Karavaeva TA, Mikhaylov VA, Vasileva AV, Poltorak SV, Polyakov AYu, Morgacheva TV, Safonova NY. A comparative study of the efficacy of personality-oriented (reconstructive) and cognitive-behavioral psychotherapy in neurotic anxiety disorders with insomnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(42):60–66. (In Russ.). doi: 10.17116/jnev-ro20181184260

43. Hmylova TN. Dynamics of the anxiety disorders in the course of short-term psychotherapy. Bulletin of psychotherapy. 2007;22(27):127–128. (In Russ.).